We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 46

10% more funds holding

Funds holding: 124 → 137 (+13)

3% more capital invested

Capital invested by funds: $3.13B → $3.23B (+$103M)

0.72% more ownership

Funds ownership: 88.96% → 89.68% (+0.72%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$95.8M
2
PA
Perceptive Advisors
New York
+$52.6M
3
Bank of America
Bank of America
North Carolina
+$38.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
5
CCM
Consonance Capital Management
New York
+$24.1M

Top Sellers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$114M
2
O
OrbiMed
New York
-$95.5M
3
DM
Deerfield Management
New York
-$69.3M
4
Goldman Sachs
Goldman Sachs
New York
-$16.1M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$11.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
CAAS Capital Management
New York
$16.5M +$7.08M +90,364 +67%
LCM
27
Laurion Capital Management
New York
$16.1M +$2.32M +29,586 +16%
Ameriprise
28
Ameriprise
Minnesota
$14.2M -$551K -7,033 -4%
Jennison Associates
29
Jennison Associates
New York
$13.6M +$14.5M +185,085 New
Charles Schwab
30
Charles Schwab
California
$13.2M +$464K +5,920 +3%
WP
31
Woodline Partners
California
$12.9M +$3.56M +45,496 +35%
SB
32
Samsara BioCapital
California
$12.5M -$7.26M -92,720 -35%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$11.1M +$6.47M +82,667 +122%
Goldman Sachs
34
Goldman Sachs
New York
$10.3M -$16.1M -206,017 -60%
SFM
35
Sphera Funds Management
Israel
$10.1M +$8.33M +106,372 +340%
Morgan Stanley
36
Morgan Stanley
New York
$9.85M +$4.75M +60,696 +83%
CS
37
Candriam SCA
Luxembourg
$9.47M -$78 -1 -0%
CAM
38
Cormorant Asset Management
Massachusetts
$9.2M – – –
Axa
39
Axa
France
$8.22M +$8.75M +111,709 New
CIBC Asset Management
40
CIBC Asset Management
Ontario, Canada
$7.83M -$3.87M -49,480 -32%
TG
41
TCW Group
California
$7.37M -$1.76M -22,491 -18%
Invesco
42
Invesco
Georgia
$7.21M +$7.34M +93,772 +2,222%
CM
43
Castleark Management
Illinois
$6.91M +$1.43M +18,300 +24%
N
44
Nuveen
North Carolina
$6.84M -$903K -11,534 -11%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$6.62M -$165K -2,102 -2%
AA
46
ALPS Advisors
Colorado
$6.49M +$126K +1,615 +2%
Millennium Management
47
Millennium Management
New York
$5.74M -$3.32M -42,403 -35%
Deutsche Bank
48
Deutsche Bank
Germany
$4.97M +$3.81M +48,605 +257%
Marshall Wace
49
Marshall Wace
United Kingdom
$4.79M +$5.09M +65,044 New
Renaissance Technologies
50
Renaissance Technologies
New York
$4.48M +$2.41M +30,800 +102%
1
2
3 4 5

SWTX Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2021, worth a combined $3.23B — up 3.3% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $95.8M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $114M.

  • 137 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2021, up from 124 in Q4 2020.
  • Funds reported $3.23B of SpringWorks Therapeutics stock for Q1 2021, up 3.3% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q1 2021 and 12 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $95.8M added.
  • The largest SpringWorks Therapeutics seller in Q1 2021 was Bain Capital Life Sciences Investors, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2021.